Stockscreener 앱 받기
38.58
3.04%
1.14
시장 영업 전:
40.37
1.79
+4.64%
Revolution Medicines Inc 주식(RVMD)의 최신 뉴스
Revolution Medicines Inc (RVMD) is an excellent investment, but the stock is overvalued/undervalued right now - uspostnews.com
RVMD Stock Sees Surge of Approximately 3.08% in Last Five Days - knoxdaily.com
This trade activity should not be overlooked: Revolution Medicines Inc (RVMD) - Sete News
Revolution Medicines to Participate in April 2025 Investor Conferences - GlobeNewswire
Revolution Medicines at Stifel Forum: RAS-Driven Cancer Insights By Investing.com - Investing.com Canada
Revolution Medicines: Overpriced RAS-Addicted Cancers Maven (NASDAQ:RVMD) - Seeking Alpha
Revolution Medicines stock hits 52-week low at $30.02 - Investing.com Australia
Revolution Medicines at Needham Conference: Progress in Cancer Treatment - Investing.com Australia
Revolution Medicines at Needham Conference: Progress in Cancer Treatment By Investing.com - Investing.com Canada
Revolution Medicines stock hits 52-week low at $30.02 By Investing.com - Investing.com India
When the Price of (RVMD) Talks, People Listen - news.stocktradersdaily.com
Revolution Medicines to Deliver Multiple Presentations at the 2025 American Association for Cancer Research (AACR) Annual Meeting - The Manila Times
Revolution Medicines to Deliver Multiple Presentations at - GlobeNewswire
Groundbreaking Lung Cancer Drug Data Revealed: Revolution Medicines' First Clinical Results - Stock Titan
Revolution Medicines (RVMD): The Best Debt Free Mid Cap Stock to Buy Now - MSN
Revolution Medicines Brings Groundbreaking RAS Cancer Research to Major Healthcare Forums - Stock Titan
Revolution Medicines Inc [RVMD] Stock sold by Insider Cislini Jeff for $79008.0 - knoxdaily.com
Is Revolution Medicines (RVMD) the Best Mid Cap Biotech Stock to Buy? - Insider Monkey
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Revolution Medicines general counsel Jeff Cislini sells $79,008 in stock By Investing.com - Investing.com South Africa
Revolution Medicines general counsel Jeff Cislini sells $79,008 in stock - Investing.com
Revolution Medicines executive sells shares worth $128,598 By Investing.com - Investing.com Australia
Revolution Medicines’ general counsel sells $56,920 in stock By Investing.com - Investing.com Australia
Revolution Medicines CEO Mark Goldsmith sells $458,255 in stock By Investing.com - Investing.com Australia
Revolution Medicines CFO Jack Anders sells $72,771 in stock By Investing.com - Investing.com Canada
Revolution Medicines’ general counsel sells $56,920 in stock - Investing.com India
Revolution Medicines CFO Jack Anders sells $72,771 in stock - Investing.com
Revolution Medicines Executives Sell Shares - TradingView
Revolution Medicines Inc (RVMD) Should Be Considered For The Next Few Weeks - Stocks Register
Earnings To Watch: Revolution Medicines Inc (RVMD) Reports Q4 20 - GuruFocus.com
Revolution Medicines at Leerink Conference: Expanding RAS Inhibitor Reach By Investing.com - Investing.com Canada
Revolution Medicines’ SWOT analysis: RAS inhibitor stock shows promise amid clinical trials - Investing.com Canada
Revolution Medicines’ SWOT analysis: RAS inhibitor stock shows promise amid clinical trials By Investing.com - Investing.com South Africa
Revolution Medicines at Barclays Conference: Focus on Pancreatic Cancer Trials - Investing.com UK
Discovery of Daraxonrasib (RMC-6236), a Potent and Orally Bioavailable RAS(ON) Multi-selective, Noncovalent Tri-complex Inhibitor for the Treatment of Patients with Multiple RAS-Addicted Cancers | Journal of Medicinal Chemistry - ACS Publications
Is Revolution Medicines, Inc. (RVMD) Among Stocks With At Least $20 Million In Insider Spending Recently? - Insider Monkey
10 Stocks With At Least $20 Million In Insider Spending Recently - Insider Monkey
Revolution Medicines’ Earnings Call: Positive Progress Amid Rising Costs - TipRanks
HC Wainwright Issues Positive Forecast for Revolution Medicines (NASDAQ:RVMD) Stock Price - Defense World
Revolution Medicines, Inc. (RVMD): Among the Cash-Rich Mid Cap Stocks to Buy Now - Yahoo Finance
10 Cash-Rich Mid Cap Stocks To Buy Now - Insider Monkey
Revolution Medicines’ (RVMD) “Outperform” Rating Reiterated at Wedbush - Armenian Reporter
Long Term Trading Analysis for (RVMD) - Stock Traders Daily
Wedbush Reaffirms Outperform Rating for Revolution Medicines (NASDAQ:RVMD) - Defense World
New Treatments Give Hope to Patients With One of the Deadliest Cancers - WSJ
2.04%
2.60%
자본화:
|
볼륨(24시간):